Tubular fluid flow, urine osmolality, and pH were selectively altered to determine the relative protective roles of these factors in a rat model of acute urate nephrophathy. Various prehyper uricemic conditions were established in five groups of animals: (a) normopenic Wistar rats given no pretreatment (Group I); (b) Wistar rats given acetazolamide, 20 mg/kg, and isotonic NaHCO3 to produce urine alkalinization (Group II); (c) Wistar rats in which a moderate diuresis, similar to that observed in Group II but without urine alkalinization, was induced with furosemide, 2 mg/kg (Group III); (d) Wistar rats in which a high-flow solute diuresis was induced with furosemide, 15 mg/kg (Group IV); (e) Brattleboro rats, homozygous for pituitary diabetes insipidus, that had a spontaneous high-flow water diuresis (Group V). A comparable level of hyperuricemia (19.4+/-2.2 mg/100 ml) was achieved in all animals with intravenous urate infusion. Clearance and micropuncture studies were performed before and 1 h after induction of hyperuicemia. Group I rats had mean falls in renal plasma flow and glomerular filtration rate of 83 and 86%, respectively; nephron filtration rate decreased 66%, and tubular and microvascular pressures increased twofold. In Group II there were 45 and 47% declines in renal plasma flow and glomerular filtration rate, respectively, a 66% fall in nephron filtration rate, and a 30% increase in tubular and vascular pressures. A B S T R A C T Tubular fluid flow, urine osmolality, and pH were selectively altered to determine the relative protective roles of these factors in a rat model of acute urate nephropathy. Various prehyperuricemic conditions were established in five groups of animals: (a) normopenic Wistar rats given no pretreatment (Group I); (b) Wistar rats given acetazolamide, 20 mg/kg, and isotonic NaHCO3 to produce urine alkalinization (Group II); (c) Wistar rats in which a moderate diuresis, similar to that observed in Group II but without urine alkalinization, was induced with furosemide, 2 mg/kg (Group III); (d) Wistar rats in which a high-flow solute diuresis was induced with furosemide, 15 mg/kg (Group IV); (e) Brattleboro rats, homozygous for pituitary diabetes insipidus, that had a spontaneous high-flow water diuresis (Group V). A comparable level of hyperuricemia (19.4+2.2 mg/100 ml) was achieved in all animals with intravenous urate infusion. Clearance and micropuncture studies were performed before and 1 h after induction of hyperuricemia. Group I rats had mean falls in renal plasma flow and glomerular filtration rate of 83 and 86%, respectively; nephron filtration rate decreased 66%, and tubular and microvascular pressures increased twofold. In Group II there were 45 and 47% declines in renal plasma flow and glomerular filtration rate, respectively, a 66% fall in nephron filtration rate, and a 30% increase in tubular and vascular pressures. Moderate amounts of urate were seen in the kidneys. Group III had changes in renal function identical to Group II suggesting that the moderate prehyperuricemic diuresis in the latter group and not urine alkalinization produced the partial protection observed. Groups IV Portions of this study appeared in abstract form in the
INTRODUCTION
It is an established clinical observation that abrupt renal failure can occur as the result of uric acid and urate deposition within the kidney (1) (2) (3) (4) (5) (6) (7) (8) . Although hyperuricemia per se is considered to be the necessary and immediate cause of this disorder, the relatively poor correlation between the plasma urate level and degree of renal dysfunction (5) (6) (7) (8) (9) suggests that additional factors must modify the rate of uric acid and urate precipitation and the severity of consequent renal damage. In vitro studies have shown the importance of solvent pH and ionic strength in determining the solubility of uric acid and its sodium salt (10) (11) (12) . These findings have been the basis for the use of forced diuresis and urine alkalinization in the treatment of acute urate nephropathy (13) . However, neither the actual mechanism of protection nor the relative efficacy ofthese two modalities of management have been determined, since the critical intrarenal factors that lead to uric acid and urate deposition in the in vivo setting have not been clearly established.
An animal model recently developed in our laboratory (14) seemed to lend itself to an investigation of the roles of intrarenal dynamics in the pathogenesis and prevention of acute urate nephropathy. The effects of changes in tubular fluid flow rate, urine pH, and urine osmolality on the magnitude of renal damage from acute hyperuricemia were evaluated in the rat with clearance, micropuncture, and morphologic techniques.
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The results indicated that high tubular fluid flow rate induced by either a solute or water diuresis was the primary factor preventing the development of acute urate nephropathy. Urine alkalinization had no detectable protective effect in this model.
METHODS
The model of acute urate nephropathy is described in detail in a previous report (14) . Male Wistar rats and Brattleboro rats, homozygous for hypothalamic diabetes insipidus, and weighing 250-300g, were fasted overnight but permitted free access to water. They were anesthetized with pentobarbital (60 mg/kg i.p.) and supplemental doses of pentobarbital (5) (6) (7) (8) (9) (10) mg/kg i.v.) were given as necessary during the study. After anesthesia oxonic acid (250 mg/kg), a uricase inhibitor, was given intraperitoneally. The rats were placed on a heated surgical table (370C) and prepared for clearance and micropuncture experiments as previously outlined (14) . Polyethylene catheters were placed in the right external jugular vein, left renal vein via the right femoral vein, right femoral artery, and the ureter of the left kidney which had been positioned for micropuncture. The femoral artery catheter was attached to a pressure transducer (model 267B, Hewlett-Packard Co., Palo Alto, Calif.) and the blood pressure recorded on a Hewlett-Packard recorder (model 7702B). Isotonic Ringer's solution containing inulin, para-aminohippurate (PAH)l and oxonic acid was infused via the jugular vein catheter at 50 IL/kg per min in Wistar rats. For Brattleboro rats the infusion rate was adjusted to match spontaneous urine flow rate as estimated from the 24-h volume before study. The average rate of delivery into these Brattleboro rats was 150 ±30 ,ul/min. The concentrations of inulin and PAH were sufficient to give plasma levels of 50-100 mg/100 ml and 2-4 mg/100 ml, respectively. Oxonic acid content was adjusted to deliver 2 mg/kg per min. 1 h before the experiments, 1 ml of blood was removed from the femoral artery and replaced with an equal volume of isotonic Ringer's solution. Aliquots of this blood equal in volume to samples taken for inulin, PAH, and urate analysis were returned to the animal during the study to maintain stability of hematocrit.
To determine the effects of tubular fluid flow rate, urine pH, and osmolality on the severity of kidney damage from hyperuricemia, the rats were divided into five groups each receiving a different treatment before hyperuricemia was induced (Table I) . Group I included Wistar rats given no pretreatment. Group II included Wistar rats in which urine alkalinization was produced by giving acetazolamide intravenously (20 mg/kg per h) and a maintenance infusion of isotonic sodium bicarbonate. The latter was given at the same rate and with the same inulin, PAH, and oxonic acid content as the isotonic Ringer's solution described above. Group III contained Wistar rats in which a diuresis quantitatively similar to that observed in Group II was established, but without a change in urine pH (UpH). This was accomplished by giving intravenous furosemide, 2.0 mg/kg. Group IV included Wistar rats in which a high flow solute diuresis was induced by the intravenous injection of furosemide (15 mg/kg). Group V contained Brattle-' Abbreviations used in this paper: GFR, glomerular filtration rate; PAH, para-aminohippurate; P,,te, plasma urate concentration; RPF, renal plasma flow; SNGFR, single nephron GFR; Uosm, urine osmolality; UpH, urine pH; U,rate, urinary urate concentration; V, urine flow rate. boro rats with a spontaneous high-flow water diuresis. They were given no specific treatment except for the adjustment in Ringer's solution infusion rate described above. Urine losses were replaced with equal volumes of isotonic Ringer's solution in Groups III and IV and with isotonic sodium bicarbonate in Group II. 30 min after beginning the selected pretreatment, all animals were subjected to the following experimental protocol.
Control studies. Samples of femoral artery (0.4 ml) and renal vein blood (0.1 ml) were obtained between two timed 50-,A collections of urine. Inulin, PAH, and urate concentrations were determined on blood and urine samples. Osmolality and pH were measured on urine samples. Timed collections of tubular fluid were obtained from four or five last proximal tubular loops with oil-filled micropipettes (8-10 j,m OD) as previously described (15) . Using a servo-null pressure apparatus (Instrumentation for Physiology and Medicine, San Diego, Calif.), hydrostatic pressures were measured in 5-10 proximal tubules, 3-5 efferent arterioles, and 5-10 peritubular capillaries.
Experimental studies. After the control measurements were completed, lithium urate,2 prepared by dissolving uric acid in a warmed solution of saturated lithium carbonate and adjusted to pH of 7.4, was injected into the jugular catheter over 5 min. The total dose was 300 mg/kg delivered in a volume of 3 ml. Femoral artery blood (0.3 ml) for urate concentration was obtained 3 min after the injection, the time when urate achieved its highest level in the plasma. 1 h later repeat femoral artery and renal vein blood and ureteral urine collections for inulin, PAH, urate, osmolality, and pH were obtained. Repeat tubular fluid collections were made from four to five new last proximal tubular sites. During collection, the intratubular pressure existing in that tubule was monitored with a pressure pipette positioned just distal to the oil block. Fluid collection was controlled to maintain pressure constant. Hydrostatic pressures were remeasured in proximal tubules, efferent arterioles, and peritubular capillaries.
Morphologic studies. A detailed description of both the gross and microscopic lesions in this model has been reported previously (14) . ,ul/min which was higher than that of the untreated animals (P < 0.005). After urate infusion the rise in plasma urate from 1.8±0.4 to 17.3±2.4 mg/100 ml was similar to that of Group I. Despite the alkaline UpH, renal function declined significantly after induction of hyperuricemia. RPF fell to 55% anid GFR to 43% of their control values (both P < 0.001). Urine flow rate decreased to 6.6±2.0 Al/min (P < 0.001). SNGFR fell from 29.4±8.3 nl/min to 11.4±2.2 nl/min (P < 0.01) and proximal tubule absolute reabsorption was reduced from 11.8±5.4 to 4.4±0.7 nl/min (P < 0.02). Proximal tubule hydrostatic pressure was increased by 50 percent (P < 0.01); efferent arteriole and peritubular capillary hydrostatic pressures rose by 27 and 30%, respectively (both P < 0.005). While 3 In a previous study the deposits were found to be crystals with an appearance compatible with uric acid and urate salts. These were located within collecting ducts and vasa recti. The possibility that some of the deposits represented carbonate salts was excluded by demonstrating a lack of deposits when infusions of lithium carbonate equimolar to lithium urate were substituted for the latter (14) . the fall in renal function in Group II was highly significant when compared to prehyperuricemic parameters, the declines in RPF and GFR and elevations of tubular and vascular pressures were less than those in Group I animals (all P < 0.01).
The cut section of a kidney from a Group II rat is shown in Fig. 2B . There was a moderate amount of crystal deposition in the medulla and papilla, but less than that noted in Group I kidneys.
To determine whether the partial protection of renal function observed in Group II rats was a consequence of urine alkalinization or the moderate diuresis present before urate infusion, the results were compared to those in Group III. The latter group had a prehyperuricemic urine flow rate of 38.3+4.9 ,ul/min which was not different from that for Group II, but the UpH of 5.8+0.1 was significantly more acid than that of Group IL (P < 0.001) and similar to that of Group I. After urate infusion, the decline in renal function in Group III was nearly identical to that of Group II (Fig. 1) . In the former animals RPF fell from 3,588+460 to 1,634+277 ,ul/min. In the latter group the same parameter was reduced from 3,614 +300 to 1,982 ,ul/min. Likewise, the fall in GFR in Group III (944±+139 to 528±+138 ,ul/min) was the same as that of Group II (1,019+159 to 538+293 ul/min). The decreases in urine flow rate (V) also were not different between the two groups. When comparing micropuncture results, there was a close parallel with the clearance studies. There were like declines in SNGFR and similar increases in micropressure measurements for the two groups.
The cut sections of Group III kidneys, as illustrated in Fig. 2C, had a were occasional streaks of uric acid in the papillae, otherwise there were no abnormalities detected on cut sections (Fig. 2D ). There were rare patchy crystalline deposits noted in the kidneys of two rats. In three of five animals no crystals were seen (Fig. 2E ). DISCUSSION The predominant abnormalities in this model of hyperuricemia with acute renal failure (Group I) were tubular and vascular obstruction resulting in marked declines of renal blood flow and glomerular filtration (14) . The underlying pathologic lesion was the deposition within collecting ducts, deep cortical, and medullary vessels of uric acid and urate crystals. The biochemical factors that predispose to urate deposition are in large part related to the solubility characteristics of this substance according to in vitro studies (10) (11) (12) . Plasma urate is present primarily as the sodium salt and the normally measured levels are relatively close to the in vitro determined solubility limit (10) (11) (12) . A number of properties peculiar to the renal environment enhance the tendency to urate precipitation within this organ. These include active secretion of urate (18, 19) , the renal concentrating mechanism, and the pH of tubular fluid relative to the pKa of uric acid. The effects of these factors are to increase the concentration of urate in the tubular system and convert the major fraction of the ionized salt form to the less soluble acid form at pH levels achieved beyond the distal tubule.4 Even at normal filtered levels of urate, conditions are frequently such that the solubility of uric acid as determined by in vitro measurements is approached or exceeded in the final urine (10) . Based on these measurements, it is not surprising that marked hyperuricemia, as occurs in neoplastic diseases and as was mimicked by the present experiments, should lead to deposition of urates and uric acid in the kidney. On the other hand, there is considerable clinical evidence that despite such marked hyperuricemia the degree of renal dysfunction that results is highly variable (5) (6) (7) (8) (9) . For this reason the present set of experiments was designed to examine the importance of dynamic factors within the kidney in the pathogenesis and prevention of acuite urate nephropathy. The roles of tubular fluid flow rate, UpH, and Uosm were studied by selectively altering these parameters in a setting of relatively constant hyperuricemia.
High-flow water diuresis (Group V
V was of greatest significance in determining the severity of urate deposition and renal fumnction impairment. Both the high-dose furosemide and Brattleboro rats had complete protection from the renal damage of hyperuricemia. High urinary flow rates were unique to these two groups of animals. Intermediate preservation of kidney function was associated with 4The pKa of uric acid is 5.7 (9) . Distal tubular fluid pH in normal hydropenic rats averages 6.3 (22) . the moderate diuresis of Groups II and III independent of the acid or alkaline nature of the urine. The untreated animals with low V had the most marked renal damage. When preurate V vs. percent preservation of initial GFR was plotted for all rats there was good correlation between these two parameters (r = 0.7635, P < 0.001) as shown in Fig. 3 . The simplest explanation for the efficacy of high V to prevent urate and uric acid deposition in the kidney takes into account both chemical and mechanical factors. Previous work from our laboratory has confirmed that the major tubular site of urate deposition is the collecing duct (14) . By inference from studies of renal tissue urate content during hyperuricemia, this is also the nephron segment of highest uric acid concentration (18, 20) . The effect of high V would be to lower the concentration of urate within the collecting duct enhancing its solubility and to rapidly "flush" any precipitated urate material from this tubular segment.
In support of this explanation is the finding that urinary urate concentration (Uurate) was inversely related to the V and the percent protection of renal function (r = 0.6277, p < 0.001). Although there is evidence that tubular fluid flow rates may have additional effects on urate handling by the kidney at normal plasma levels (21) , no such information is presently available for the hyperuricemic state. Uosm was high in the Group I animals and lower in the diuretic-treated and Brattleboro rats suggesting a relationship between prehyperuricemic Uosm and protection. There was a correlation between prehyperuricemia Uosm and percent preservation of initial GFR (r = 0.6774, P < 0.001). However, initial Uosm was higher in Group IV than Group V (363 +47 vs. 228+27 mosmol/liter, P < 0.001) despite similar levels of protection and was not different between Groups III and IV (359+25 vs. 363+47 mosmol/liter, P = NS) where impairment of kidney function was negligible in the former and nearly 50% in the latter. (Uosm x V) between Groups IV and V, the value for the former was more than twice that of the latter (59.3+7.7 vs. 24.3+2.9 mosmol/min) suggesting that urine flow was a much more critical factor than solute excretion rate per se, since protection was similar.
It does not seem likely that the protective effect of the high-dose furosemide was related to a drug effect blocking tubular secretion rather than promoting a diuresis for two reasons. First, in the control period the clearance of urate exceeded that of inulin indicating a net secretion of urate into the tubule and thus actually increasing the tubular load of urate. Secondly, if the protective effect were specifically related to a direct drug effect, then there should not have been equal preservation of renal function in the Bratfleboro rats that received no pharmacologic agents to promote diuresis.
Despite alkalinization of the urine to 7.9±0.2 with acetazolamide and NaHCO3 in Group II rats, only partial preservation of kidney function was seen. Moreover, it is likely that this level of protection was due to the diuretic properties of acetazolamide rather than its alkalinizing effect, since identical renal function and morphologic results were seen in the lowdose furosemide group. These latter rats had preurate urine flow rates similar to those of acetazolamide NaHCO3-treated animals but a UpH of only 5 The implications of these experiments are that maintenance of high distal nephron flow is the major factor in preventing acute urate nephropathy and that urine alkalinization is of minor importance. However, such conclusions should be drawn with considerable caution when applied to the clinical setting. There may be important species differences between rats and man that are not obviated by simply blocking uricase activity as was done in this model. Moreover, it is possible that pH-related solubility may be a more critical pathogenetic factor at levels of filtered urate and at pH values not examined in this study. For these reasons it would be inappropriate to suggest that urine alkalinization be abandoned as a therapeutic modality in hyperuricemic acute renal failure. On the other hand, the data from this investigation do seem to indicate that tubular fluid flow is the most critical pathogenetic factor in this syndrome and that the primary method of its prevention is the establishment of high rates of urine flow.
